Rodd Schlerf Joins SIGNiX as Director of Life Sciences
SIGNiX is excited to announce Rodd Schlerf has joined the team. He will focus on Life Sciences to help grow one of SIGNiX's fastest growing verticals.
CHATTANOOGA, Tenn., October 11, 2017 (Newswire.com) - SIGNiX, the leading provider of cloud-based Independent E-Signature™ solutions, announced that Rodd Schlerf has joined the team to further develop their footprint in Life Sciences. Schlerf brings over a decade of experience with digital signatures in FDA regulated use cases. He spent the last year at Biofortis and prior to that was with ARX Inc. (CoSign) for eleven years. Schlerf was responsible for Life Sciences markets at ARX, which was acquired by DocuSign in 2015.
Rodd joins SIGNiX as the Director of Life Sciences to facilitate further growth in one of SIGNiX’s fasting growing verticals. “I am excited about this opportunity with SIGNiX and the ability to positively impact and drive value for life science enterprises,” comments Rodd. “SIGNiX has invested in a strong foundation, including senior professionals from the digital signature world, an easy to integrate cloud platform, regulatory compliance and proven success with some of the largest research and pharmaceutical organizations in the world.”
We are extremely excited to have Rodd on board. He brings a wealth of experience and industry knowledge that has already proven to be very valuable. We see the addition of Rodd as a sign of our commitment to being the leading digital signature provider in Life Sciences.
Brian Felker, Vice President of Sales
“We are extremely excited to have Rodd on board,” said Brian Felker, Vice President of Sales. “He brings a wealth of experience and industry knowledge that has already proven to be very valuable. We see the addition of Rodd as a sign of our commitment to being the leading digital signature provider in Life Sciences.”
Today, SIGNiX is deployed at some of the most innovative organizations in the world and supports a variety of use cases. SIGNiX’s Independent E-Signature™ technology is compliant with HIPAA regulations for data privacy and meets the requirements of FDA 21 CFR Part 11, which makes it the premier choice for top healthcare, medical, and research organizations.
About SIGNiX, Inc.
SIGNiX, the most trusted name in Independent E-Signatures™, makes signing documents online safe and secure with comprehensive legal evidence permanently embedded in each document to eliminate any dependence upon SIGNiX. The company’s cloud-based service uses patented technology to give businesses and organizations the most secure and legally defensible e-signatures available at a fraction of the cost of wet ink signatures. SIGNiX’s products help the world’s leading companies become more efficient, decrease risk and boost profits. For more information, visit http://www.signix.com.